Search Page

1

Cite

Share

T cell homeostasis and systemic autoimmunity.

Theofilopoulos AN, Dummer W, Kono DH. Theofilopoulos AN, et al. Among authors: dummer w. J Clin Invest. 2001 Aug;108(3):335-40. doi: 10.1172/JCI12173. J Clin Invest. 2001. PMID: 11489923 Free PMC article. Review. No abstract available.

Cite

Share

2

Cite

Share

T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of action.

Jullien D, Prinz JC, Langley RG, Caro I, Dummer W, Joshi A, Dedrick R, Natta P. Jullien D, et al. Among authors: dummer w. Dermatology. 2004;208(4):297-306. doi: 10.1159/000077660. Dermatology. 2004. PMID: 15178911 Review.

Cite

Share

3

Cite

Share

Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives.

Baccala R, Gonzalez-Quintial R, Dummer W, Theofilopoulos AN. Baccala R, et al. Among authors: dummer w. Springer Semin Immunopathol. 2005 Jun;27(1):75-85. doi: 10.1007/s00281-004-0196-9. Epub 2005 Jan 22. Springer Semin Immunopathol. 2005. PMID: 15666151 Review.

Cite

Share

4

Cite

Share

Role of self-major histocompatibility complex/peptide ligands in selection and maintenance of a diverse T cell repertoire.

Surh CD, Ernst B, Lee DS, Dummer W, LeRoy E. Surh CD, et al. Among authors: dummer w. Immunol Res. 2000;21(2-3):331-9. doi: 10.1385/IR:21:2-3:331. Immunol Res. 2000. PMID: 10852134 Review.

Cite

Share

5

Cite

Share

[Pemphigoid gestationis without blisters].

Ogilvie P, Trautmann A, Dummer W, Rose C, Bröcker EB, Zillikens D. Ogilvie P, et al. Among authors: dummer w. Hautarzt. 2000 Jan;51(1):25-30. doi: 10.1007/s001050050006. Hautarzt. 2000. PMID: 10663036 German.

Cite

Share

6

Cite

Share

Late-type allergy to Ultravist (iopromid).

Otto K, Kaempgen E, Dummer W, Broecker EB, Becker JC. Otto K, et al. Among authors: dummer w. Allergy. 2003 Mar;58(3):261-2. doi: 10.1034/j.1398-9995.2003.00062_3.x. Allergy. 2003. PMID: 12653805 No abstract available.

Cite

Share

7

Cite

Share

A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis.

Owczarczyk K, Lal P, Abbas AR, Wolslegel K, Holweg CT, Dummer W, Kelman A, Brunetta P, Lewin-Koh N, Sorani M, Leong D, Fielder P, Yocum D, Ho C, Ortmann W, Townsend MJ, Behrens TW. Owczarczyk K, et al. Among authors: dummer w. Sci Transl Med. 2011 Sep 21;3(101):101ra92. doi: 10.1126/scitranslmed.3002432. Sci Transl Med. 2011. PMID: 21937757 Free article.

Cite

Share

8

Cite

Share

T cell homeostatic proliferation elicits effective antitumor autoimmunity.

Dummer W, Niethammer AG, Baccala R, Lawson BR, Wagner N, Reisfeld RA, Theofilopoulos AN. Dummer W, et al. J Clin Invest. 2002 Jul;110(2):185-92. doi: 10.1172/JCI15175. J Clin Invest. 2002. PMID: 12122110 Free PMC article.

Cite

Share

9

Cite

Share

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study.

Hendriksz CJ, Burton B, Fleming TR, Harmatz P, Hughes D, Jones SA, Lin SP, Mengel E, Scarpa M, Valayannopoulos V, Giugliani R; STRIVE Investigators, Slasor P, Lounsbury D, Dummer W. Hendriksz CJ, et al. Among authors: dummer w. J Inherit Metab Dis. 2014 Nov;37(6):979-90. doi: 10.1007/s10545-014-9715-6. Epub 2014 May 9. J Inherit Metab Dis. 2014. PMID: 24810369 Free PMC article. Clinical Trial.

Cite

Share

10

Cite

Share

A novel targeted T-cell modulator, efalizumab, for plaque psoriasis.

Lebwohl M, Tyring SK, Hamilton TK, Toth D, Glazer S, Tawfik NH, Walicke P, Dummer W, Wang X, Garovoy MR, Pariser D; Efalizumab Study Group. Lebwohl M, et al. Among authors: dummer w. N Engl J Med. 2003 Nov 20;349(21):2004-13. doi: 10.1056/NEJMoa030002. N Engl J Med. 2003. PMID: 14627785 Free article. Clinical Trial.

Cite

Share